Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Advanced brain imaging for improving deep brain stimulation in Parkinson's and essential tremor patients

Official title: The BRAINMAP-DBS Study

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06932692 · Data updated 2026-11-12

This study is testing if advanced brain imaging can help doctors place and program deep brain stimulation better for people with Parkinson's disease and essential tremor to improve their movement.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations1 site (Amsterdam, North Holland)
StatusRecruiting
StartedApril 23, 2024
Main results expectedDecember 31, 2035
Study endsDecember 31, 2035
Registry record updatedApril 17, 2025
Trial IDNCT06932692 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with idiopathic Parkinson's disease or essential tremor who have undergone at least six months of DBS and a preoperative 7-Tesla MRI scan.

Probably not a fit

Patients with spinal stimulation or DBS systems incompatible with 7-Tesla MRI, or those with non-removable implants that may interfere with MEG, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the effectiveness of deep brain stimulation (DBS) for patients with Parkinson's disease and essential tremor by utilizing advanced imaging techniques, specifically 7-Tesla MRI and magnetoencephalography (MEG). The researchers will analyze brain networks to improve electrode placement and programming of DBS, which could lead to better patient-specific treatment outcomes. By focusing on the intricate motor networks within the brain, the study seeks to address the limitations of current DBS methods that rely on lower-resolution imaging. The goal is to achieve more significant motor improvements for patients who currently experience insufficient benefits from DBS.

Why it matters

Potential benefit: If successful, this approach could significantly improve motor function in patients with Parkinson's disease and essential tremor who are currently not receiving adequate benefits from existing DBS treatments.

How similar studies have gone: Previous studies utilizing 7-Tesla MRI and MEG for brain network visualization have shown promising results, indicating that this approach is based on established methodologies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

* Age \> 18 years;
* Idiopathic PD/ET with at least six months of DBS
* Underwent a preoperative 7-Tesla MRI scan

Exclusion Criteria:

A potential subject who meets any of the following criteria will be excluded from participation in this study:

* Legally incompetent adults;
* No written informed consent.
* A spinal stimulation or deep brain stimulation system is not compatible with 7-Tesla MRI
* There a no implants inadmissible in the MEG, although patients will be questioned for possible (non-removable) implants such as pacemakerand/or dental as they may interfere with the magnetic signals

Where it's running

  • Amsterdam UMC
    Amsterdam, North Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.